Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label long-term olesoxime safety and effectiveness study in spinal muscular atrophy
NL-OMON43897Phase 2Active, not recruiting
- Sponsor
- Roche
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of olesoxime, sponsored by Roche. Started Jul 2016; status: active, not recruiting.
02
Drugs
olesoxime
Beyond the preview
Go deeper on NL-OMON43897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43897.